CVS Health Corporation: Monthly Stock Report
Publication Date: September 22, 2024
Company Overview
CVS Health Corporation, based in Woonsocket, Rhode Island, stands as a prominent leader in the healthcare industry, particularly within the Healthcare Plans sector. The company operates through three primary segments:
– Health Care Benefits: Offers a diverse range of health insurance products.
– Health Services: Specializes in pharmacy benefit management.
– Pharmacy & Consumer Wellness: Focuses on the sale of prescription and over-the-counter medications as well as health-related consumer products.
CVS Health is publicly traded and plays a crucial role in delivering integrated health solutions across the United States. With total revenue approximating $361.85 billion, the company showcases strong financial health and solid growth potential. Analysts have issued a buy recommendation, citing a favorable target high price of $77.00 per share, indicating significant upside for potential investors.
Financial Performance & Stock Analysis
CVS Health’s stock price currently rests at $57.51, presenting an appealing entry point for investors. Projections indicate a target mean price of $63.95, with a target high of $77.00, showcasing optimism regarding future performance. The average target price suggests potential growth opportunities amid a positive outlook shaped by solid revenue generation.
The company has a total of 1,257,980,032 shares outstanding, with approximately 18,495,652 shares shorted, translating to a short interest of about 1.47% of the float. This relatively low short interest signals positive investor sentiment towards the stock. Over the past year, CVS Health has demonstrated stock price volatility, with a range of $52.77 to $83.25, necessitating careful consideration for prospective investors analyzing trends and stock trajectory.
Analyst Consensus & Recommendations
The consensus among analysts remains bullish, with a recommendation mean score of 2.4 from 24 analysts, indicating a general “buy” stance. The projected target price range—target high at $77.00 and target low at $59.00—paints a favorable picture for investors interested in the healthcare sector. Investors should note that they may wish to monitor the company’s revenue and market positioning as CVS Health continues to navigate the dynamic healthcare landscape.
Overall, with its robust financial health, growing industry presence, and positive analyst sentiment, CVS Health Corporation emerges as an attractive investment option within the healthcare plans market.
| Metric | Value |
|---|---|
| Market Cap | $72.3b |
| Total Debt | $83.8b |
| Total Cash | $16.3b |
| Shares Outstanding | 1.3b |
| Float Shares | 1.3b |
Disclaimer:
The information provided in this monthly report is for informational purposes only and should not be construed as financial, investment, or trading advice. AltStation.io does not guarantee the accuracy, completeness, or timeliness of the data and analyses presented. The content is based on publicly available information, and while we strive to ensure its accuracy, errors and omissions may occur.
Investing in stocks, cryptocurrencies, and other financial instruments involves significant risk, including the potential loss of principal. Past performance is not indicative of future results. Readers should conduct their own research and consult with a qualified financial advisor before making any investment decisions. AltStation.io and its affiliates are not responsible for any losses incurred as a result of using this report.
By using this report, you acknowledge that you understand and accept these terms.